These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 23108648

  • 1. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y, Tian XY, Mao G, Fang X, Fung ML, Shyy JY, Huang Y, Wang N.
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [Abstract] [Full Text] [Related]

  • 2. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay É, Biardel S, Racine C, Courture C, Bonnet P, Majka SM, Deshaies Y, Picard F, Provencher S, Bonnet S.
    J Am Heart Assoc; 2013 Jan 16; 2(1):e005157. PubMed ID: 23525442
    [Abstract] [Full Text] [Related]

  • 3. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 16; 389(4):369-79. PubMed ID: 26742933
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
    Han X, Chen C, Cheng G, Liang L, Yao X, Yang G, You P, Shou X.
    Microvasc Res; 2015 Jul 16; 100():17-24. PubMed ID: 25937083
    [Abstract] [Full Text] [Related]

  • 5. Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension.
    Li HH, Hsu HH, Chang GJ, Chen IC, Ho WJ, Hsu PC, Chen WJ, Pang JS, Huang CC, Lai YJ.
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar 01; 314(3):L349-L359. PubMed ID: 29146573
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F.
    J Pharmacol Exp Ther; 2010 Aug 01; 334(2):364-72. PubMed ID: 20430844
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.
    Liu Y, Wang Z, Li J, Ban Y, Mao G, Zhang M, Wang M, Liu Y, Zhao B, Shen Q, Xu Q, Wang N.
    J Am Heart Assoc; 2018 Jan 30; 7(3):. PubMed ID: 29382665
    [Abstract] [Full Text] [Related]

  • 12. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q, Chen Y, Chen X, Zhang J, Lu W, Wang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May 30; 37(5):360-4. PubMed ID: 25011512
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.
    Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M.
    Circulation; 2007 Mar 13; 115(10):1275-84. PubMed ID: 17339547
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.
    Lu X, Bijli KM, Ramirez A, Murphy TC, Kleinhenz J, Hart CM.
    Free Radic Biol Med; 2013 Oct 13; 63():151-60. PubMed ID: 23684777
    [Abstract] [Full Text] [Related]

  • 20. PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.
    Lu X, Murphy TC, Nanes MS, Hart CM.
    Am J Physiol Lung Cell Mol Physiol; 2010 Oct 13; 299(4):L559-66. PubMed ID: 20622120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.